Renography before heart transplantation in patients with cardiomyopathy

被引:0
|
作者
Aigner, RM
O'Mara, RE
Fueger, GF
Tscheliessnigg, K
Nicoletti, R
Sorantin, E
Smith, EM
机构
[1] Univ Rochester Hosp, Dept Radiol, Div Nucl Med, Graz, Austria
[2] Univ Rochester Hosp, Dept Surg, Div Transplant Surg, Graz, Austria
关键词
ischemic cardiomyopathy; heart transplantation; dynamic renal scintigraphy; prognosis; renal dysfunction;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
In patients with ischemic cardiomyopathy (CM), abnormal renograms may result not only from circulatory failure (which should reverse after transplantation) but also from intrinsic renal disease (which contraindicates heart transplantation). Here, the outcome of heart transplantation was related to preoperative renograms, and the differentiating and prognostic value of renography was analyzed. Methods: The study population consisted of 50 patients with ischemic CM expecting heart transplantation. Anatomical renal pathology was excluded in all patients. Dynamic renal scintigraphy was performed with (99m)Tc-mercaptoacetyltriglycine. Background-subtracted renograms were inspected visually and characterized numerically. Mean parenchymal transit time (mPTT), renal tracer content at 15 min (RTC15) and retention index (RI) were determined. The parametric renogram values were related to a normal reference group of 64 patients. The preoperative renograms were matched with the postoperative outcome. Results: Three characteristic types of symmetrical findings in the kidneys were found: no pathological findings, mildly delayed peak and excretion phase and severely delayed peak and excretion phase. Pathological renograms were observed in 36 of 50 (72%) patients. The mean parametric renogram values in ischemic CM were as follows: Group-A (normal kidney function), mPTT = 142 +/- 26.6 sec, RTC15 = 22.3% +/- 4.6% and RI = 24.7 +/- 11.9; Group B (mild dysfunction), mPTT = 210 +/- 44.0 sec, RTC15 = 42.6% +/- 10.3% and RI = 101.4 +/- 50.5; Group C (severe dysfunction), mPTT = 320 +/- 94.2 sec, RTC15 = 79.6% +/- 15.9% and RI = 347.7 +/- 194.7; and reference patients (normal kidney function), mPTT = 137 +/- 31.1 sec, RTC15 = 22.8% +/- 3.8% and RI = 24.6 +/- 7.9. Postoperative serum creatinine levels were <1.5 mg/dl in all Group A patients, between 1.5 and 2.5 mg/dl in 78% of Group B patients and > 2.5 mg/dl in 75% of Group C patients. Conclusion: Renography revealed abnormal kidney function when structural pathology was excluded. The renographic abnormalities in ischemic CM did not reflect simply the circulatory failure. The numerical grading of renograms allowed patient stratification, suggestive of possible renal insufficiency after cardiac transplantation and immunosuppressive therapy. With further experience, renography may become a useful tool for predicting postoperative outcome in ischemic CM.
引用
收藏
页码:2153 / 2158
页数:6
相关论文
共 50 条
  • [21] Takotsubo syndrome in the same heart before and after heart transplantation
    Tsuji, Masaki
    Amiya, Eisuke
    Bujo, Chie
    Maki, Hisataka
    Ishida, Junichi
    Hatano, Masaru
    Ono, Minoru
    Komuro, Issei
    ESC HEART FAILURE, 2020, 7 (06): : 4311 - 4314
  • [22] RECONSTRUCTIVE SURGERY OF THE DONOR HEART BEFORE TRANSPLANTATION
    Akopov, G. A.
    Ivanov, A. S.
    Poptsov, V. N.
    Lugovskiv, M. K.
    Pogosyan, A. M.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2019, 21 (03): : 53 - 61
  • [23] Cardiac hepatopathy before and after heart transplantation
    Dichtl, W
    Vogel, W
    Dunst, KM
    Grander, W
    Alber, HF
    Frick, M
    Antretter, H
    Laufer, G
    Pachinger, O
    Pölzl, G
    TRANSPLANT INTERNATIONAL, 2005, 18 (06) : 697 - 702
  • [24] DONOR HEART VALVES RECONSTRUCTION BEFORE TRANSPLANTATION
    Gautier, S. V.
    Saitgareev, R. S.
    Poptsov, V. N.
    Shumakov, D. V.
    Akopov, G. A.
    Zakharevich, V. M.
    Kormer, A. Y.
    Spirina, E. A.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2013, 15 (02): : 36 - 43
  • [25] Outcomes of adults with restrictive cardiomyopathy after heart transplantation
    DePasquale, Eugene C.
    Nasir, Khurram
    Jacoby, Daniel L.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (12) : 1269 - 1275
  • [26] Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy
    Kato, Tomoko S.
    Takayama, Hiroo
    Yoshizawa, Saeko
    Marboe, Charles
    Schulze, P. Christian
    Farr, Maryjane
    Naka, Yoshifumi
    Mancini, Donna
    Maurer, Mathew S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (04) : 568 - 574
  • [27] Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation
    Rivinius, Rasmus
    Helmschrott, Matthias
    Ruhparwar, Arjang
    Darche, Fabrice F.
    Thomas, Dierk
    Bruckner, Tom
    Katus, Hugo A.
    Doesch, Andreas O.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 1827 - 1837
  • [28] PLASMA HORMONES IN PATIENTS WITH CHRONIC HEART-FAILURE BEFORE AND EARLY AFTER ORTHOTOPIC HEART-TRANSPLANTATION
    SPES, CH
    ANGERMANN, CE
    GERZER, R
    DOMINIAK, P
    WEIL, J
    BEYER, RW
    KEMKES, BM
    THEISEN, K
    ZEITSCHRIFT FUR KARDIOLOGIE, 1991, 80 (09): : 580 - 584
  • [29] Waitlist Mortality of Patients With Amyloid Cardiomyopathy who Are Listed for Heart Transplantation and Implications for Organ Allocation
    Panhwar, Muhammad S.
    Al-Kindi, Sadeer G.
    Tofovic, David
    Oliveira, Guilherme H.
    Ginwalla, Mahazarin
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (09) : 767 - 771
  • [30] Kidney Transplantation in Patients With a Prior Heart Transplant
    Cassuto, James R.
    Reese, Peter
    Bloom, Roy D.
    Doyle, Alden
    Goral, Simin
    Naji, Ali
    Abt, Peter L.
    TRANSPLANTATION, 2010, 89 (04) : 427 - 433